Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017.

Kohler P, Fulchini R, Albrich WC, Egli A, Balmelli C, Harbarth S, Héquet D, Kahlert CR, Kuster SP, Petignat C, Schlegel M, Kronenberg A.

Antimicrob Resist Infect Control. 2018 Jul 20;7:88. doi: 10.1186/s13756-018-0378-1. eCollection 2018.

2.

Measles in Returning Adult Travelers.

Kositz C, Albrich WC.

Am J Trop Med Hyg. 2018 Jul;99(1):5-6. doi: 10.4269/ajtmh.18-0053. No abstract available.

3.

Prediction of Bacteriuria Based on Clinical or Laboratory Parameters in Patients with Indwelling Ureteral Stents Before Ureterorenoscopy Should Not Substitute for Urine Cultures.

Weber A, Zumstein V, Betschart P, Albrich WC, Nolte O, Engeler DS, Schmid HP, Güsewell S, Abt D.

J Endourol. 2018 Aug;32(8):739-745. doi: 10.1089/end.2018.0256. Epub 2018 Jul 2.

PMID:
29848057
4.

Hand hygiene adherence in relation to influenza season during 6 consecutive years.

Fulchini R, Kohler P, Kahlert CR, Albrich WC, Kuhn R, Hoffmann M, Schlegel M.

Am J Infect Control. 2018 May 18. pii: S0196-6553(18)30429-2. doi: 10.1016/j.ajic.2018.04.203. [Epub ahead of print]

PMID:
29784445
5.

Infection Rate after Cranial Neurosurgical Procedures: A Prospective Single-Center Study.

Strahm C, Albrich WC, Zdravkovic V, Schöbi B, Hildebrandt G, Schlegel M.

World Neurosurg. 2018 Mar;111:e277-e285. doi: 10.1016/j.wneu.2017.12.062. Epub 2017 Dec 18.

PMID:
29269070
6.

Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk.

Rassouli F, Baty F, Stolz D, Albrich WC, Tamm M, Widmer S, Brutsche MH.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 24;12:3103-3109. doi: 10.2147/COPD.S141646. eCollection 2017.

7.

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia.

Huttner A, Albrich WC, Bochud PY, Gayet-Ageron A, Rossel A, Dach EV, Harbarth S, Kaiser L.

BMJ Open. 2017 Jul 13;7(7):e017996. doi: 10.1136/bmjopen-2017-017996.

8.

Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study.

Mayer LM, Kahlert C, Rassouli F, Vernazza P, Albrich WC.

Pneumonia (Nathan). 2017 Feb 25;9:4. doi: 10.1186/s41479-017-0028-z. eCollection 2017.

9.

Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trial.

Carreño JM, Perez-Shibayama C, Gil-Cruz C, Lopez-Macias C, Vernazza P, Ludewig B, Albrich WC.

PLoS One. 2017 Jun 1;12(6):e0178669. doi: 10.1371/journal.pone.0178669. eCollection 2017.

10.

Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy.

Albrich WC, Huttner BD, Huttner A.

JAMA Intern Med. 2017 Feb 1;177(2):283-284. doi: 10.1001/jamainternmed.2016.8574. No abstract available.

PMID:
28166342
11.

Biofilm formation on ureteral stents - Incidence, clinical impact, and prevention.

Zumstein V, Betschart P, Albrich WC, Buhmann MT, Ren Q, Schmid HP, Abt D.

Swiss Med Wkly. 2017 Feb 3;147:w14408. doi: 10.4414/smw.2017.14408. eCollection 2017. Review.

12.

Detection of Shigella sonnei in a respiratory specimen in a patient with subacute atypical pneumonia.

Nahid H, Staub D, Hächler H, Albrich WC.

Infection. 2017 Apr;45(2):241-244. doi: 10.1007/s15010-016-0967-y. Epub 2016 Dec 1.

PMID:
27909896
13.

Multiplex Urinary Antigen Detection for 13 Streptococcus pneumoniae Serotypes Improves Diagnosis of Pneumococcal Pneumonia in South African HIV-Infected Adults.

Albrich WC, Pride MW, Madhi SA, Callahan J, Adrian PV, French R, van Niekerk N, Sebastian S, Souza V, Telles JN, Paranhos-Baccalà G, Jansen KU, Klugman KP.

J Clin Microbiol. 2016 Dec 28;55(1):302-312. doi: 10.1128/JCM.01573-16. Print 2017 Jan.

14.

Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014.

Olearo F, Albrich WC, Vernaz N, Harbarth S, Kronenberg A; Swiss Centre For Antibiotic Resistance Anresis.

Swiss Med Wkly. 2016 Sep 15;146:w14339. doi: 10.4414/smw.2016.14339. eCollection 2016.

15.

Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia.

Wirz SA, Blum CA, Schuetz P, Albrich WC, Noppen C, Mueller B, Christ-Crain M, Tarr PE; STEP Study Group.

Eur Respir J. 2016 Oct;48(4):1150-1159. doi: 10.1183/13993003.00474-2016. Epub 2016 Jul 28.

16.

[Pneumococcal vaccination for children and adults].

Albrich W.

Ther Umsch. 2016;73(5):235-40. doi: 10.1024/0040-5930/a000785. Review. German.

PMID:
27268445
17.

[Vaccinations].

Albrich W.

Ther Umsch. 2016;73(5):229-30. doi: 10.1024/0040-5930/a000783. German. No abstract available.

PMID:
27268443
18.

The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens.

Messaoudi M, Milenkov M, Albrich WC, van der Linden MP, Bénet T, Chou M, Sylla M, Barreto Costa P, Richard N, Klugman KP, Endtz HP, Paranhos-Baccalà G, Telles JN.

PLoS One. 2016 Mar 17;11(3):e0151428. doi: 10.1371/journal.pone.0151428. eCollection 2016.

19.

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.

Albrich WC, Harbarth S.

Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21. Review.

PMID:
26194026
20.

Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial.

Drozdov D, Schwarz S, Kutz A, Grolimund E, Rast AC, Steiner D, Regez K, Schild U, Guglielmetti M, Conca A, Reutlinger B, Ottiger C, Buchkremer F, Haubitz S, Blum C, Huber A, Buergi U, Schuetz P, Bock A, Fux CA, Mueller B, Albrich WC.

BMC Med. 2015 May 1;13:104. doi: 10.1186/s12916-015-0347-y.

21.

Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults.

Albrich WC, Madhi SA, Adrian PV, Telles JN, Paranhos-Baccalà G, Klugman KP.

J Clin Microbiol. 2014 Dec;52(12):4224-9. doi: 10.1128/JCM.01553-14. Epub 2014 Sep 24.

22.

Pulmonary actinomycosis and Hodgkin's disease: when FDG-PET may be misleading.

Weisshaupt C, Hitz F, Albrich WC, Omlin A.

BMJ Case Rep. 2014 Sep 22;2014. pii: bcr2014206034. doi: 10.1136/bcr-2014-206034.

23.

The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.

Dusemund F, Chronis J, Baty F, Albrich WC, Brutsche MH.

Swiss Med Wkly. 2014 Sep 3;144:w14013. doi: 10.4414/smw.2014.14013. eCollection 2014.

24.

Pneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia.

Albrich WC, Madhi SA, Adrian PV, van Niekerk N, Telles JN, Ebrahim N, Messaoudi M, Paranhos-Baccalà G, Giersdorf S, Vernet G, Mueller B, Klugman KP.

BMJ Open. 2014 Aug 11;4(8):e005953. doi: 10.1136/bmjopen-2014-005953.

25.

Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study.

Meichtry J, Born R, Küffer M, Zwahlen M, Albrich WC, Brugger SD, Mühlemann K, Hilty M.

Vaccine. 2014 Sep 8;32(40):5185-91. doi: 10.1016/j.vaccine.2014.07.060. Epub 2014 Jul 28.

26.

[A fever of finally known origin].

Jenni S, Kositz C, Diethelm M, Albrich W.

Praxis (Bern 1994). 2014 May 21;103(11):657-61. doi: 10.1024/1661-8157/a001673. German.

PMID:
24846891
27.

Effectiveness of Proadrenomedullin Enhanced CURB65 Score Algorithm in Patients with Community-Acquired Pneumonia in "Real Life", an Observational Quality Control Survey.

Widmer D, Drozdov D, Rüegger K, Litke A, Arici B, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Kouegbe RB, Reutlinger B, Blum C, Schuetz P, Irani S, Huber A, Bürgi U, Müller B, Albrich WC.

J Clin Med. 2014 Mar 14;3(1):267-79. doi: 10.3390/jcm3010267.

28.

Hyponatremia and anti-diuretic hormone in Legionnaires' disease.

Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B; ProHOSP Study Group.

BMC Infect Dis. 2013 Dec 11;13:585. doi: 10.1186/1471-2334-13-585.

29.

Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.

Drozdov D, Thomer A, Meili M, Schwarz S, Kouegbe RB, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Reutlinger B, Ottiger C, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux CA, Bock A, Müller B, Albrich WC; Triple P study group.

Trials. 2013 Mar 22;14:84. doi: 10.1186/1745-6215-14-84.

30.

The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.

Litke A, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, Schäfer P, Reutlinger B, Mueller B, Albrich WC.

Infection. 2013 Aug;41(4):799-809. doi: 10.1007/s15010-013-0423-1. Epub 2013 Feb 24.

PMID:
23435720
31.

Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia.

Schuetz P, Litke A, Albrich WC, Mueller B.

Curr Opin Infect Dis. 2013 Apr;26(2):159-67. doi: 10.1097/QCO.0b013e32835d0bec. Review.

PMID:
23434895
32.

[At admission planning discharge already].

Conca A, Regez K, Schild U, Reutlinger B, Schäfer P, Schweingruber R, Tobias P, Bürgi U, Schirlo S, Müller B, Albrich WC.

Krankenpfl Soins Infirm. 2013;106(1):20-3. German. No abstract available.

PMID:
23405447
33.

Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial.

Albrich WC, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum CA, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, Schäfer P, Schubert M, de Geest S, Reutlinger B, Irani S, Bürgi U, Huber A, Müller B.

Eur Respir J. 2013 Oct;42(4):1064-75. doi: 10.1183/09031936.00113612. Epub 2013 Jan 24.

34.

Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections.

Drozdov D, Dusemund F, Müller B, Albrich WC.

Antibiotics (Basel). 2013 Jan 22;2(1):1-10. doi: 10.3390/antibiotics2010001.

35.

Multidisciplinary Assessment to Personalize Length of Stay in Acute Decompensated Heart Failure (OPTIMA II ADHF).

Dusemund F, Steiner M, Vuilliomenet A, Muller C, Bossart R, Regez K, Schild U, Conca A, Huber A, Reutlinger B, Muller B, Albrich WC.

J Clin Med Res. 2012 Dec;4(6):402-9. doi: 10.4021/jocmr1154w. Epub 2012 Nov 11.

36.

Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection.

Hartmann O, Schuetz P, Albrich WC, Anker SD, Mueller B, Schmidt T.

Int J Cardiol. 2012 Nov 29;161(3):166-73. doi: 10.1016/j.ijcard.2012.09.014. Epub 2012 Sep 24.

PMID:
23017815
37.

Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia.

Labarère J, Schuetz P, Renaud B, Claessens YE, Albrich W, Mueller B.

Acad Emerg Med. 2012 Sep;19(9):993-1003. doi: 10.1111/j.1553-2712.2012.01424.x.

38.

Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.

Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich WC; ProREAL Study Team.

Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):51-60. doi: 10.1007/s10096-012-1713-8. Epub 2012 Aug 12.

PMID:
22886090
39.

Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance.

Groome MJ, Albrich WC, Wadula J, Khoosal M, Madhi SA.

Paediatr Int Child Health. 2012 Aug;32(3):140-6. doi: 10.1179/1465328111Y.0000000044.

PMID:
22824661
40.

Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).

Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B; ProREAL Study Team.

Arch Intern Med. 2012 May 14;172(9):715-22. doi: 10.1001/archinternmed.2012.770. Erratum in: Arch Intern Med. 2014 Jun;174(6):1011.

PMID:
22782201
41.

Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia.

Renaud B, Schuetz P, Claessens YE, Labarère J, Albrich W, Mueller B.

Chest. 2012 Dec;142(6):1447-1454. doi: 10.1378/chest.11-2574.

PMID:
22661450
42.

Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Suter-Widmer I, Christ-Crain M, Zimmerli W, Albrich W, Mueller B, Schuetz P; ProHOSP Study Group.

BMC Pulm Med. 2012 May 20;12:21. doi: 10.1186/1471-2466-12-21.

43.

Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia.

Albrich WC, Madhi SA, Adrian PV, van Niekerk N, Mareletsi T, Cutland C, Wong M, Khoosal M, Karstaedt A, Zhao P, Deatly A, Sidhu M, Jansen KU, Klugman KP.

Clin Infect Dis. 2012 Mar 1;54(5):601-9. doi: 10.1093/cid/cir859. Epub 2011 Dec 8.

44.

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Schuetz P, Albrich W, Mueller B.

BMC Med. 2011 Sep 22;9:107. doi: 10.1186/1741-7015-9-107. Review.

45.

Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections.

Albrich WC, Rüegger K, Dusemund F, Bossart R, Regez K, Schild U, Conca A, Schuetz P, Sigrist T, Huber A, Reutlinger B, Müller B.

Swiss Med Wkly. 2011 Jul 30;141:w13237. doi: 10.4414/smw.2011.13237. eCollection 2011.

46.

Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia.

Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, Henzen C, Krause M, Schoenenberger R, Zimmerli W, Mueller B.

Swiss Med Wkly. 2011 Jul 18;141:w13228. doi: 10.4414/smw.2011.13228. eCollection 2011.

47.

A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Rether C, Conen A, Grossenbacher M, Albrich WC.

Infection. 2011 Dec;39(6):583-5. doi: 10.1007/s15010-011-0148-y. Epub 2011 Jun 30.

PMID:
21717147
48.

Predicting bacteremia by procalcitonin levels in patients evaluated for sepsis in the emergency department.

Albrich WC, Mueller B.

Expert Rev Anti Infect Ther. 2011 Jun;9(6):653-6. doi: 10.1586/eri.11.42.

PMID:
21692670
49.

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

Albrich WC, Dusemund F, Rüegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B, Schuetz P.

BMC Infect Dis. 2011 May 3;11:112. doi: 10.1186/1471-2334-11-112.

50.

Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.

Schuetz P, Christ-Crain M, Albrich W, Zimmerli W, Mueller B; ProHOSP Study Group.

Virulence. 2010 Mar-Apr;1(2):88-92. doi: 10.4161/viru.1.2.10488.

PMID:
21178422

Supplemental Content

Loading ...
Support Center